In line with those results, we are currently examine the FZD3 protein expression in their respective primary tumors for those 11 types of metastatic non-CRC carcinomas which have high level of FZD3 protein expression in order to have a more understanding on the role of FZD3 protein in various carcinogenesis pathways. This evidence concerns the gene FZD3 and colorectal carcinoma.